CN102727528B - Hemorrhoid treatment medicine and preparation method thereof - Google Patents
Hemorrhoid treatment medicine and preparation method thereof Download PDFInfo
- Publication number
- CN102727528B CN102727528B CN2012102070546A CN201210207054A CN102727528B CN 102727528 B CN102727528 B CN 102727528B CN 2012102070546 A CN2012102070546 A CN 2012102070546A CN 201210207054 A CN201210207054 A CN 201210207054A CN 102727528 B CN102727528 B CN 102727528B
- Authority
- CN
- China
- Prior art keywords
- hemorrhoid
- parts
- medicine
- treatment
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 115
- 208000014617 hemorrhoid Diseases 0.000 title claims abstract description 105
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 229940079593 drug Drugs 0.000 claims abstract description 51
- 239000000843 powder Substances 0.000 claims abstract description 28
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims abstract description 13
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 19
- 229910052717 sulfur Inorganic materials 0.000 claims description 19
- 239000011593 sulfur Substances 0.000 claims description 19
- 239000002956 ash Substances 0.000 claims description 14
- 235000002918 Fraxinus excelsior Nutrition 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 239000011812 mixed powder Substances 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 239000008280 blood Substances 0.000 abstract description 28
- 210000004369 blood Anatomy 0.000 abstract description 28
- 230000000694 effects Effects 0.000 abstract description 25
- 208000002193 Pain Diseases 0.000 abstract description 11
- 230000036407 pain Effects 0.000 abstract description 11
- 230000000740 bleeding effect Effects 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 241001161070 Calomela Species 0.000 abstract description 2
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 229910052956 cinnabar Inorganic materials 0.000 abstract description 2
- 238000001816 cooling Methods 0.000 abstract description 2
- 230000005764 inhibitory process Effects 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 229940037003 alum Drugs 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 201000007772 internal hemorrhoid Diseases 0.000 description 15
- 210000000436 anus Anatomy 0.000 description 10
- 208000032843 Hemorrhage Diseases 0.000 description 9
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 9
- 239000008194 pharmaceutical composition Substances 0.000 description 8
- 241000283956 Manis Species 0.000 description 6
- 238000002651 drug therapy Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 241000951471 Citrus junos Species 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 206010003694 Atrophy Diseases 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 241000628997 Flos Species 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 230000037444 atrophy Effects 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 230000002147 killing effect Effects 0.000 description 4
- 210000003097 mucus Anatomy 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 235000019615 sensations Nutrition 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000016583 Anus disease Diseases 0.000 description 3
- 235000009392 Vitis Nutrition 0.000 description 3
- 241000219095 Vitis Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 2
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 239000003716 antitrichomonal agent Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000028774 intestinal disease Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002153 Anal fissure Diseases 0.000 description 1
- 206010065360 Anal prolapse Diseases 0.000 description 1
- 206010068172 Anal pruritus Diseases 0.000 description 1
- 208000019751 Anorectal disease Diseases 0.000 description 1
- 102000016904 Armadillo Domain Proteins Human genes 0.000 description 1
- 108010014223 Armadillo Domain Proteins Proteins 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000289632 Dasypodidae Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000009531 Fissure in Ano Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000167847 Koelreuteria paniculata Species 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 241001057584 Myrrha Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 206010033971 Paratyphoid fever Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000009544 Pruritus Ani Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000015815 Rectal disease Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 210000002255 anal canal Anatomy 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- ZADYMNAVLSWLEQ-UHFFFAOYSA-N magnesium;oxygen(2-);silicon(4+) Chemical compound [O-2].[O-2].[O-2].[Mg+2].[Si+4] ZADYMNAVLSWLEQ-UHFFFAOYSA-N 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 229910052957 realgar Inorganic materials 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000003229 sclerosing agent Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 229910052714 tellurium Inorganic materials 0.000 description 1
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a hemorrhoid treatment medicine and its preparation method. The hemorrhoid treatment medicine comprises the following raw medicines, by weight, 180-220 parts of alum, 3-8 parts of cinnabar, 3-8 parts of Calomelas, 3-8 parts of sulfurous ash, 4-8 parts of stir-baked Squama Manitis and 3-7 parts of talcum powder. The hemorrhoid treatment medicine of the invention combines the raw medicines, and has the effects of convergence, bleeding stopping, bacterial inhibition and blood circulation invigorating to remove the stasis, anti-inflammation and detumescence to relive pains, heat clearing and detoxifying, blood cooling and pain relieving, and stasis breaking and detumescence, so the hemorrhoid treatment effect can be reached by the medicine. The hemorrhoid treatment medicine of the invention can thoroughly and fundamentally treat the hemorrhoid, and the fundamental treatment effect can be reached through directly applying medicine powder on the haemorrhoids to make the haemorrhoids be dry, hard and shrunk. The hemorrhoid treatment medicine of the invention has the advantages of short treatment period, substantial curative effect, low cost and no side effect, the cure rate reaches above 90%, and the effective rate reaches 98%.
Description
Technical field
The present invention relates to a kind of medicine, particularly relate to a kind of medicine for the treatment of hemorrhoid and preparation method thereof.
Background technology
Hemorrhoid are the distinctive commonly encountered diseases of the mankind, frequently-occurring disease, according to relevant reconnaissance information, show, the sickness rate of anorectal disease is 59.1%, hemorrhoid account for 87.25% in all anal and intestinal diseases, and wherein common with internal hemorrhoid, account for 52.19% of all anal and intestinal diseases, the men and women all can fall ill, women's sickness rate is 67% left and right, male's sickness rate is about 53.9%, and any age all can fall ill, and wherein the people of 20~40 years old is comparatively common, and increase the weight of with advancing age and gradually, therefore saying of " ten people's nine hemorrhoid " arranged.Analyze reason, mostly that transconversion into heat is dry humorously by giving birth in the factor such as damp and hot inner product,, the sitting standing for a long time pungent without joint, surfeit of drinking so that body, damp and hot being detained, the foul smell blood stasis makes a bet that anus causes under the mucosa of rectum lower end and the subcutaneous hemorrhoidal plexus varicose of anal canal and form the vein agglomerate and the hemorrhoid called.Because sending out position is different, there isd again dividing of external hemorrhoid, hemorrhoids.Clinical symptoms is swollen, the pain of pendant, foreign body sensation is arranged, and is hemorrhage during stool, and abnormal sensory is arranged, and severe patient has block from anal prolapse, has a strong impact on the healthy of patient.At present, doctor trained in Western medicine adopts the therapies such as operation, ligation, injection more, has because the recurrence Repeated Operation causes fistula, What is more moving badly anal sphincter, to patient, causes great misery, can only cure the symptoms, not the disease, and can not effectively effect a radical cure hemorrhoid.
At present, utilize the medicine of Chinese herbal treatment hemorrhoid more and more, have for oral administrationly, external, but therapeutic effect is mostly not satisfactory.As Pilulae Fructus Sophorae, the Radix Sanguisorbae Fructus Sophorae, the analgesic effect of these medicines and not obvious, do not subside a swelling in 3~5 days, the disappearance that can not come off of two weeks blood stasis, and internal hemorrhoid can not heal in one month.Therefore, people better treat the very large demand of medicine existence of hemorrhoid to curative effect.
Patents bibliographical information about treatment hemorrhoid Chinese medicine is more.For example: 1, application number is 200610099014.9, name is called the patent of invention of " medicines for the treatment of hemorrhoid ", and the drug main of the disclosed treatment hemorrhoid of this patent of invention will be made by Folium Nelumbinis, Herba Cirsii, Herba Portulacae, Flos Sophorae, Rhizoma Imperatae and Cortex Ziziphi spinosae Radicis.2, application number is 200810058078.3, name is called the patent of invention of " suppositorys for the treatment of hemorrhoid ", and the suppository of the disclosed treatment hemorrhoid of this patent is mainly made by the crude drug Fructus Sophorae, Radix Notoginseng, Radix Sophorae Flavescentis, Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Cnidii, Herba Patriniae, Folium Artemisiae Argyi, Herba Portulacae, Flos Lonicerae, Radix Saposhnikoviae, Alumen, Borax, Borneolum Syntheticum and Radix Glycyrrhizae.3, application number 200710017821.6, name are called the patent of invention of " a kind of medicine for the treatment of hemorrhoid ", and the disclosed medicine for treaching hemorrhoie of this patent of invention is mainly made by crude drug Radix Sophorae Flavescentis, Radix Bupleuri, Cortex Phellodendri, Herba Taraxaci, Herba Portulacae, Folium Pyrrosiae, Radix Sanguisorbae, Flos Carthami, Radix Angelicae Sinensis, Radix Paeoniae Rubra, Flos Sophorae, Radix Et Rhizoma Rhei, Olibanum and Myrrha.
Summary of the invention
The technical problem to be solved in the present invention is to provide that a kind of therapeutic effect is good, instant effect, short treating period, a kind of medicine for the treatment of hemorrhoid of being free from side effects and preparation method thereof.Pharmaceutical formulation advantages of simple of the present invention, preparation manipulation is simple and easy, is easy to promote the use of; And therapeutic effect is remarkable, and its cure rate reaches more than 90%, and effective percentage reaches 98%.
In order to address the above problem, the technical solution used in the present invention is:
The invention provides a kind of medicine for the treatment of hemorrhoid, with weight portion, represent, the medicine of described treatment hemorrhoid is by 180~220 parts, crude drug Alumen, 3~8 parts, Cinnabaris, 3~8 parts of Calomelass, 3~8 parts of sulfur ashes, 4~8 parts of stir-baked SQUAMA MANITISs and 3~7 parts of compositions of Pulvis Talci.
According to the medicine of above-mentioned treatment hemorrhoid, the medicine of described treatment hemorrhoid is by 200 parts, crude drug Alumen, 5 parts, Cinnabaris, 5 parts of Calomelass, 5 parts of sulfur ashes, 6 parts of stir-baked SQUAMA MANITISs and 5 parts of compositions of Pulvis Talci.
According to the medicine of above-mentioned treatment hemorrhoid, the powdered product that described sulfur ash obtains through burning for sulfur.
A kind of preparation method of medicine of above-mentioned treatment hemorrhoid, described preparation method is: according to the raw material of the medicine of above-mentioned treatment hemorrhoid, form and take various crude drug, at first crude drug Alumen is added in marmite and heats, heating is dissolved and is calcined to dried-uply, obtains dried Alumen and pulverizes; Other crude drug that then will take is ground into smalls, obtains mixed powder, and mixed powder is joined in dried Alumen after pulverizing and is uniformly mixed, the powder medicated powder of the hemorrhoid that obtain medical treatment, sealed storage, standby.
Adopt the roughly therapeutic process of the various hemorrhoid of Drug therapy of the present invention as follows:
During utilizing the medication of Drug therapy hemorrhoid of the present invention, hemorrhoid itself can not got well, and blood stasis is sent out greatly on the contrary, it is destructurized that blood stasis sends out the proof blood stasis large, can ooze a little mucus, and blood stasis is not to connect root to come off, but own atrophy after drug withdrawal, withered, thereby reach the effect of effecting a radical cure hemorrhoid.
Adopt Drug therapy hemorrhoid of the present invention, the medication that may occur reaction: after medication 1-2 days, start to have the hypodynia sensation, blood stasis sends out the stream mucus large; Adhered to medication seven days, after drug withdrawal, pain fades away, and blood stasis is atrophy gradually; The recovery from illness of the lighter's first quarter moon left and right; Severe one is fully recovered about January, does not recur.
The pharmacological action of the various crude drug that the present invention adopts:
Alumen: this product is cold in nature, sour-puckery flavor, has stronger astriction.The traditional Chinese medical science thinks, Alumen has the detoxifcation parasite killing, and is quick-fried wet antipruritic, hemostasis antidiarrheal, the effect of heat clearing away expectorant.Studies confirm that in recent years, Alumen also have the effects such as antibiotic, anti-trichomonas vaginitis.In some, medical Alumen is treated the diseases such as hyperlipemia, duodenal ulcer, hemoptysis of pulmonary tuberculosis.
Alumen can powerful solidifying protein, and is clinical in digestion, hemostasis, hidroschesis, antidiarrheal, and as sclerosing agent; But broad-spectrum antiseptic, all have in various degree bacteriostasis to multiple gram-positive cocci, gram negative bacilli, some anaerobe, skin moss bacterium, Candida albicans etc.; Bacillus pyocyaneus, escherichia coli, staphylococcus aureus had obvious inhibitory action; Have an obvious anti-trichomonas vaginitis effect external, can also promote ulcer healing, purify the chaos unboiled water.
Cinnabaris: this product sweet in the mouth, cold nature; Slightly poisonous, the GUIXIN warp.Effect: this product have clear away heart-fire relieving convulsion, the effects such as detoxifcation of calming the nerves; Be usually used in palpitation and being susceptible to fright, insomnia and dreamful sleep, epilepsy is gone mad, infantile convulsion, blurring of vision, aphtha, sore throat, the cards such as sore swollen toxin.
Modern medicine study: this product mainly contains cinnabar, also is mingled with the materials such as Realgar, apatite, asphalitine.Cinnabaris has calmness, hypnosis, anticonvulsant action, and external has inhibition and killing action to skin bacterium and parasite.
Calomelas: this product acrid in the mouth, cold in nature is poisonous; Enter liver, kidney two warps.Function cures mainly: this product has parasite killing, counteracting toxic substances, diuretic, the effects such as relieving constipation.Commonly used control scabies, scrofula, syphilis, primary sore, skin ulcer, edema, tympanites, defecation such as closes at the card.
Modern medicine study: the main chloride containing mercurous of this product.This product has antifungic action, discharge function, the effects such as diuresis.
Sulfur: this product sour in the mouth, warm in nature.External use anti pruritic parasite killing furuncle; The fiery supporing yang relieving constipation of benefit for oral administration.External treatment is used for scabies, tinea alba, carbuncle of yin nature malignant boil; For oral administration for the sexual impotence cold foot, dyspnea due to deficiency cold asthma, deficiency and coldness constipation.Enter the loose clothes of ball after for oral administration the process of preparing Chinese medicine; Outer clothes are ground oil into powder and are transferred the coating affected part.
Medical research now: the main sulfur-bearing of this product still contains tellurium and selenium, normal assorted have earth and organic matter etc.This product has Inhibitory Effect to brain stem, has antitussive, phlegm-dispelling functions, antiinflammatory action, and laxative action, kill the effect of sarcoptic mite, sterilization and fungicidal effect.In addition, can be used for treating for skin disease.
Stir-baked SQUAMA MANITIS: the i.e. Squama Manis of the process process of preparing Chinese medicine.The process of preparing Chinese medicine is a kind of processing method commonly used of medical material at Chinese medicine, is exactly to fry substantially, generally with husky, fry or with salt, fries.Stir-baked SQUAMA MANITIS is the scale of Squama Manis(parched).
The scute of Squama Manis is the important component of Chinese medicine for a long time always, its property of medicine: Squama Manis salty in the mouth, cold nature enter liver, stomach two warps.The Squama Manis scale of the traditional Chinese medical science is divided into armadillo scale, processs Squama Manis, stir-baked SQUAMA MANITIS.Effect: have detumescence suppuration, scattered silt collateral dredging, stimulate the menstrual flow, stimulating milk secretion, invigorating blood circulation analgesia etc.Cure mainly: the card such as commonly used control that the carbuncle skin ulcer is swollen, anemofrigid-damp arthralgia, amenorrhea, galactostasis, hemostasis, disease crust gather.
Pulvis Talci: this product sweet in the mouth, light, cold in nature; Enter bladder, lung, stomach warp.Effect: this product has inducing diuresis for treating stranguria syndrome, clearing away summer-heat, the effects such as damp eliminating sore.Be usually used in pyretic stranguria, stranguria caused by urinary stone, urinate hot puckery pain, heat-damp in summer excessive thirst, dysuria, damp and hot watery diarrhea, hematodiarrhoea, jaundice, edema, the cards such as Skin wet and rotten; External treatment eczema, eczema, the cards such as miliaria.
Modern medicine study: the main magnesium silicate of this product, wherein magnesium oxide 31.7%, silicon oxide 63.5%, water 4.8%; The salic impurity that waits in addition.This product has protection skin and mucosa effect, has antibacterial action (Bacillus typhi and paratyphoid fever bacillus are had inhibitory action, meningococcus is had slight bacteriostasis).
Positive beneficial effect of the present invention:
1, the present invention treats the medicine of hemorrhoid, and all medicines of its various crude drug share, and have convergence, hemostasis, antibacterial, blood circulation promoting and blood stasis dispelling, antiinflammatory, reducing swelling and alleviating pain, and heat-clearing and toxic substances removing, cooling blood and relieving pain, the effect of removing blood stasis with potent drugs detumescence, thus reach the effect for the treatment of hemorrhoid.The medicine that the present invention treats hemorrhoid is a kind of hemorrhoid good recipe of controlling.
2, the present invention's medicine for the treatment of hemorrhoid can thoroughly effect a radical cure hemorrhoid, and drug powder of the present invention directly acts on blood stasis and makes its dry and hard, atrophy, thereby reaches the effect of radical cure.The present invention treats the Drug therapy cycle of hemorrhoid short (medication is generally seven days), evident in efficacy, cost is low, have no side effect.
3, adopt the various hemorrhoid of Drug therapy of the present invention, do not need operation, no pain, expense is low, and healing time is short, and cure rate reaches more than 90%, and effective percentage reaches 98%.
Utilize the clinical statistics data of the various hemorrhoid patients of Drug therapy of the present invention:
Through 900 routine patients' clinical use, male patient's 587 examples wherein, female patient's 313 examples, in the medication object 3 years old half of the age minimum, maximum 79 years old.Wherein internal hemorrhoid patient 196 examples, all cure; External hemorrhoid patient's 200 examples, cure 195 examples, effective 4 examples, invalid 1 example; Mixed hemorrhoid patient's 180 examples, cure 176 examples, effective 4 examples; Proctoptosis patient's (belonging to internal hemorrhoid) 134 examples, cure 133 examples, invalid 1 example; Anal fistula patient's 60 examples, cure 56 examples, invalid 4 examples; Internal hemorrhoid with bleeding+anal fissure patient's 130 examples, all cure.
The using method of medicine of the present invention: medicine of the present invention is medicine for external use, and drug powder of the present invention is applied in blood stasis, uses safety, convenient, and the medication cycle is short, is generally a week, and medication once every night.
The hemorrhoid diagnostic criteria:
Internal hemorrhoid: show as and have blood in stool, proctoptosis, pruritus, stream mucus, fall swollen, anal eczema and constipation.
External hemorrhoid: show as pendant swollen, pain, have foreign body sensation and fistulae arranged.
Mixed hemorrhoid: show as inside and outside hemorrhoid symptomes complice.
Criterion of therapeutical effect:
The recovery from illness standard: the symptom of internal hemorrhoid, external hemorrhoid, mixed hemorrhoid disappears fully.
Effective standard:
(1), internal hemorrhoid: have blood in stool, pruritus, stream mucus, fall swollen, the transference cure of anal eczema and constipation thereof, proctoptosis alleviates;
(2), external hemorrhoid: fall swollen, pain and the transference cure of foreign body sensation is arranged, fistulae alleviates;
(3), mixed hemorrhoid: be the general performance of effective standard of internal hemorrhoid, external hemorrhoid.
Invalid standard: the symptom of internal hemorrhoid, external hemorrhoid, mixed hemorrhoid does not change.
Model case:
1, in certain, Xiangcheng City pays people from market town, the man, and 40 years old, be diagnosed as internal hemorrhoid with bleeding (belonging to internal hemorrhoid), anal is hemorrhage for a long time, goes out insufficiency of blood or not hemorrhage when not on fire, in case get angry, amount of bleeding increases, and often takes medicine, uses all kinds of ZHICHUANG GAO, does not feel any better.In February, 2011, here was medical, smeared the powder (pharmaceutical formulation of its powder is referring to embodiment 1) that the present invention treats hemorrhoid, smear every day one time, and medication seven days, after drug withdrawal, amount of bleeding reduces gradually, recovery from illness afterwards in ten days.Follow up a case by regular visits to after 1 year, not recurrence.
2, Wang, Xiangcheng City pay people from market town, the man, and 36 years old, be diagnosed as the hemorrhoid of itching (belonging to external hemorrhoid), anus is moist, with the naked eye watches, and anus is without extremely, and whether regardless of on fire, often pruritus is hard to bear, and moist with anus, and it is the same that perceptual image goes out sticky sweat, often smears medicine invalid.In March, 2008, here was medical, started to smear the powder (pharmaceutical formulation of powder is referring to embodiment 1) that the present invention treats hemorrhoid, smear every day one time, and medication seven days, after drug withdrawal, pruritus ani, the moist symptom of anus all fade away, recovery from illness afterwards in ten days.Follow up a case by regular visits to after half a year, not recurrence.
3, teacher, Zheng Guo people from town, Xiangcheng City, man, 50 years old, ill ten years, be diagnosed as mixed hemorrhoid, usually anus has the blood stasis of size as Semen arachidis hypogaeae outward, squats for a long time or during stool, deviate from again the blood stasis of Fructus Vitis viniferae sample size from anal, dyschesia, once performed the operation twice at ordinary times, after again the recurrence.In November, 2009, here was medical, smear the powder (pharmaceutical formulation of powder is referring to embodiment 6) that the present invention treats hemorrhoid, every night is while deviating from until internal hemorrhoid, hemorrhoid-eliminating powder evenly is applied in inside and outside hemorrhoid surface and root place, medication seven days, after drug withdrawal, inside and outside blood stasis all dwindles gradually, fully recovers after January.Follow up a case by regular visits to after a year and a half, not recurrence.
4, high certain, Zheng Guo people from town, Xiangcheng City, the man, 45 years old, be diagnosed as ring-type hemorrhoid (belonging to external hemorrhoid), cluster round at ordinary times four blood stasis around anus, large as Semen arachidis hypogaeae, little of niblet, when inflammation was on fire, it is large that blood stasis becomes, twinge, all inconvenience of sitting, action.In November, 2008, here was medical, smeared the powder (pharmaceutical formulation of powder is referring to embodiment 7) that the present invention treats hemorrhoid, and evenly be applied in blood stasis surface and root place with medicated powder every night, medication seven days, and after drug withdrawal, four blood stasis all dwindle gradually, recovery from illness in 20 days.Follow up a case by regular visits to after 2 years, not recurrence.
5, goldenrain tree, Yongfeng, Xiangcheng City village people, the female, 42 years old, be diagnosed as internal hemorrhoid, medium-and-large-sized.Ill 3 years, anus was normal at ordinary times, when on fire, from anal, deviate from blood stasis as large in Semen Juglandis, needed just can get on hand rest, and hurt like hell, seek medical advice invalid everywhere.In February, 2011 here diagnosis and treatment, smear the powder (pharmaceutical formulation of powder is referring to embodiment 7) that the present invention treats hemorrhoid, medication seven days, and once, drug withdrawal was fully recovered after one month in medication every night, so far no recurrence.
6, field, the Wang Ming of Xiangcheng City mouth village people, female, 46 years old, be diagnosed as proctoptosis+external hemorrhoid, ill 5 years, anal orifice has one of the equally large blood stasis of Semen arachidis hypogaeae at ordinary times, stool or while squatting for a long time, anal is along routing up, approximately digit is thick, and hurt like hell is handicapped, rest for a few days and just can recover voluntarily, in case get angry, defecate, while squatting for a long time, just deviate from again, caused very big inconvenience to life, sought medical advice everywhere, can only respite.In November, 2010, the here treatment, smeared the powder (pharmaceutical formulation of powder is referring to embodiment 1) that the present invention treats hemorrhoid, and medication once every night, medication seven days, recovery from illness in 40 days after drug withdrawal, defecate, while getting angry in along no longer deviating from, anal orifice external hemorrhoid blood stasis atresia, not recurrence so far.
7, fourth, Guan Hui people from town, Xiangcheng City, the man, 38 years old, be diagnosed as hemorrhoid complicated with prolapse of rectum (belonging to internal hemorrhoid).Ill 4 years, anus is normal at ordinary times, when getting angry, squatting for a long time or defecating, anal is along routing up, and width and thickness is a finger nearly, and anus is middle along with deviating from three blood stasis large as Fructus Vitis viniferae, and with hemorrhage on a small quantity, wiping is unclean for a long time greatly after an action of the bowels, and abnormal pain, can get on hand rest, live very inconvenient, dare not perform the operation.Carry out the here treatment in December, 2010, rout up, when blood stasis is deviate from, with warm clear water, clean up until the anal edge every night, the powder of the present invention being treated hemorrhoid evenly is applied in affected part (pharmaceutical formulation of powder is referring to embodiment 1), especially root place, medication seven days, after drug withdrawal 45 days, get angry, squat for a long time or during stool, anal is along no longer deviating from, the large blood stasis of Fructus Vitis viniferae sample also atrophy is no longer deviate from, stopped bleeding, not recurrence so far.
Four, the specific embodiment:
Further illustrate the present invention below in conjunction with embodiment, but do not limit content of the present invention.
Embodiment 1:
The present invention treats the medicine of hemorrhoid, with weight portion, represents, the medicine of described treatment hemorrhoid is by 200 parts, crude drug Alumen, 5 parts, Cinnabaris, 5 parts of Calomelass, 5 parts of sulfur ashes, 6 parts of stir-baked SQUAMA MANITISs and 5 parts of compositions of Pulvis Talci;
The powdered product that described sulfur ash obtains through burning for sulfur.
Embodiment 2: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of hemorrhoid, with weight portion, represents, the medicine of described treatment hemorrhoid is by 210 parts, crude drug Alumen, 4 parts, Cinnabaris, 6 parts of Calomelass, 7 parts of sulfur ashes, 7 parts of stir-baked SQUAMA MANITISs and 4 parts of compositions of Pulvis Talci.
Embodiment 3: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of hemorrhoid, with weight portion, represents, the medicine of described treatment hemorrhoid is by 220 parts, crude drug Alumen, 6 parts, Cinnabaris, 4 parts of Calomelass, 7 parts of sulfur ashes, 5 parts of stir-baked SQUAMA MANITISs and 6 parts of compositions of Pulvis Talci.
Embodiment 4: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of hemorrhoid, with weight portion, represents, the medicine of described treatment hemorrhoid is by 180 parts, crude drug Alumen, 7 parts, Cinnabaris, 8 parts of Calomelass, 4 parts of sulfur ashes, 8 parts of stir-baked SQUAMA MANITISs and 7 parts of compositions of Pulvis Talci.
Embodiment 5: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of hemorrhoid, with weight portion, represents, the medicine of described treatment hemorrhoid is by 190 parts, crude drug Alumen, 4.5 parts, Cinnabaris, 5.5 parts of Calomelass, 6 parts of sulfur ashes, 4 parts of stir-baked SQUAMA MANITISs and 5 parts of compositions of Pulvis Talci.
Embodiment 6: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of hemorrhoid, with weight portion, represents, the medicine of described treatment hemorrhoid is by 205 parts, crude drug Alumen, 4.8 parts, Cinnabaris, 5 parts of Calomelass, 5 parts of sulfur ashes, 5.5 parts of stir-baked SQUAMA MANITISs and 4.8 parts of compositions of Pulvis Talci.
Embodiment 7: substantially the same manner as Example 1, difference is:
The present invention treats the medicine of hemorrhoid, with weight portion, represents, the medicine of described treatment hemorrhoid is by 195 parts, crude drug Alumen, 5.2 parts, Cinnabaris, 5 parts of Calomelass, 5.5 parts of sulfur ashes, 6.5 parts of stir-baked SQUAMA MANITISs and 5 parts of compositions of Pulvis Talci.
The dosage form that above-described embodiment 1~7 the present invention treats the medicine of hemorrhoid is powder, and the preparation method of powder is:
Form and to take various crude drug according to the raw material of the medicine for the treatment of hemorrhoid in above-described embodiment, at first crude drug Alumen is added in marmite and heats, heating is dissolved and is calcined to dried-uply, obtains dried Alumen and pulverizes; Other crude drug that then will take is ground into smalls, obtains mixed powder, and mixed powder is joined in dried Alumen after pulverizing and is uniformly mixed, the powder medicated powder of the hemorrhoid that obtain medical treatment, sealed storage, standby.
Claims (4)
1. medicine for the treatment of hemorrhoid is characterized in that: represent with weight portion, the medicine of described treatment hemorrhoid is by 180~220 parts, crude drug Alumen, 3~8 parts, Cinnabaris, 3~8 parts of Calomelass, 3~8 parts of sulfur ashes, 4~8 parts of stir-baked SQUAMA MANITISs and 3~7 parts of compositions of Pulvis Talci.
2. the medicine for the treatment of hemorrhoid according to claim 1 is characterized in that: the medicine of described treatment hemorrhoid is by 200 parts, crude drug Alumen, 5 parts, Cinnabaris, 5 parts of Calomelass, 5 parts of sulfur ashes, 6 parts of stir-baked SQUAMA MANITISs and 5 parts of compositions of Pulvis Talci.
3. the medicine for the treatment of hemorrhoid according to claim 1 and 2, is characterized in that: the powdered product that described sulfur ash obtains through burning for sulfur.
4. the preparation method of the medicine of the described treatment hemorrhoid of claim 1, it is characterized in that, described preparation method is: according to the raw material of the medicine of the described treatment hemorrhoid of claim 1, form and take various crude drug, at first crude drug Alumen is added in marmite and heats, heat fused also is calcined to dried-uply, obtains dried Alumen and pulverizes; Other crude drug that then will take is ground into smalls, obtains mixed powder, and mixed powder is joined in dried Alumen after pulverizing and is uniformly mixed, the powder medicated powder of the hemorrhoid that obtain medical treatment, sealed storage, standby.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012102070546A CN102727528B (en) | 2012-06-21 | 2012-06-21 | Hemorrhoid treatment medicine and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012102070546A CN102727528B (en) | 2012-06-21 | 2012-06-21 | Hemorrhoid treatment medicine and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102727528A CN102727528A (en) | 2012-10-17 |
CN102727528B true CN102727528B (en) | 2013-11-20 |
Family
ID=46984295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012102070546A Expired - Fee Related CN102727528B (en) | 2012-06-21 | 2012-06-21 | Hemorrhoid treatment medicine and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102727528B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103006707A (en) * | 2012-12-27 | 2013-04-03 | 李辉 | Chinese medicinal external ointment for treating hemorrhoids |
CN104257936A (en) * | 2014-10-31 | 2015-01-07 | 窦小林 | Formula of external application medicine for treating cervical erosion |
CN105012493A (en) * | 2015-08-31 | 2015-11-04 | 许晶 | Traditional Chinese medicine preparation for treating hemorrhagic hemorrhoids and preparation method of traditional Chinese medicine preparation |
CN105902711A (en) * | 2016-05-24 | 2016-08-31 | 成都市斯贝佳科技有限公司 | Oral administration medicament for treating hemorrhoids and application thereof |
CN106377734A (en) * | 2016-11-14 | 2017-02-08 | 河南中医药大学 | Postoperative care solution for anorectal diseases |
CN108066374A (en) * | 2018-02-10 | 2018-05-25 | 吕宝宾 | A kind of externally applied drug for treating hemorrhoid and production method |
CN110169993A (en) * | 2019-06-28 | 2019-08-27 | 刘克 | Complex composition containing Coelomactra antiquata and its preparation method and application |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1183973A (en) * | 1996-12-02 | 1998-06-10 | 张宗江 | Externally used piles powder or ointment |
CN101919876A (en) * | 2010-07-19 | 2010-12-22 | 田举 | Drug for treating haemorrhoids |
-
2012
- 2012-06-21 CN CN2012102070546A patent/CN102727528B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1183973A (en) * | 1996-12-02 | 1998-06-10 | 张宗江 | Externally used piles powder or ointment |
CN101919876A (en) * | 2010-07-19 | 2010-12-22 | 田举 | Drug for treating haemorrhoids |
Also Published As
Publication number | Publication date |
---|---|
CN102727528A (en) | 2012-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102727528B (en) | Hemorrhoid treatment medicine and preparation method thereof | |
CN102406761B (en) | Traditional Chinese medicine oil for treating burn, scald or acute and chronic ulcer sore surface and preparation method thereof | |
CN100531768C (en) | Medicament for treating chronic prostatitis and prostatic hyperplasia | |
CN101485852A (en) | Chinese medicinal liquid preparation for treating gynaecologic disease | |
CN101919975B (en) | Traditional Chinese medicine composition for treating prostatitis | |
CN102078549B (en) | Traditional Chinese medicine for treating oxyuriasis | |
CN102671070A (en) | Traditional Chinese medicine composition for treating cancers or tumors | |
CN113384670B (en) | Kidney-protecting enema prescription for delaying progress of chronic kidney disease | |
CN105194135A (en) | Hemorrhoids ointment, preparation method and application of hemorrhoids ointment | |
CN105055621A (en) | Medicine lotion for treating anus diseases and perianal eczema as well as preparation method of medicine lotion | |
CN104524275A (en) | Chinese medicinal tablet for promoting recovery of patients from operation for bladder cancer preparation method thereof | |
CN104043089A (en) | Medical biological dressing suppository for treating hemorrhoid | |
CN103860722A (en) | External-application liquid medicine for treatment of perianal eczema and preparation method thereof | |
CN103908600A (en) | Externally-applied medicine for treating rheumatoid arthritis damp-heat blockage symptom as well as preparation method and administration method thereof | |
CN103656291B (en) | Medicine for treating pharyngitis and preparation method thereof | |
CN104971332A (en) | Traditional Chinese medicine for treating hemorrhoids | |
CN105168579A (en) | Externally-used traditional Chinese medicine liquid capable of effectively treating perianal eczema and preparation method | |
CN103690654A (en) | Pharmaceutical composition for treating infantile diarrhea | |
CN103550621B (en) | Traditional Chinese medicine preparation for quickly treating rosacea | |
CN102085267A (en) | Traditional Chinese medicinal washing liquid for treating female vulvitis | |
CN101972317B (en) | Medicament for treating fallopian tube obstructive infertility | |
CN105213658A (en) | A kind of Chinese medicine lotion for the treatment of allergic eczema and preparation method thereof | |
CN106729248A (en) | It is a kind of to treat Chinese medicine composition of pudendal pruritus and preparation method thereof | |
CN105343707A (en) | Traditional Chinese medicine used for treating erythema annulare centrifugum | |
CN101391066B (en) | Traditional Chinese medicine decoction for treating psoriasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131120 |
|
CF01 | Termination of patent right due to non-payment of annual fee |